118 related articles for article (PubMed ID: 37179055)
1. Combining orthogonal measurements to unveil diclofenac encapsulation into polymeric and lipid nanocarriers.
Marques SS; Cant DJH; Minelli C; Segundo MA
Anal Chim Acta; 2023 Jun; 1262():341234. PubMed ID: 37179055
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
3. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
4. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
[TBL] [Abstract][Full Text] [Related]
5. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
Turk CT; Oz UC; Serim TM; Hascicek C
AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.
Cetin M; Atila A; Kadioglu Y
AAPS PharmSciTech; 2010 Sep; 11(3):1250-6. PubMed ID: 20697984
[TBL] [Abstract][Full Text] [Related]
8. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin.
Hafezi Ghahestani Z; Alebooye Langroodi F; Mokhtarzadeh A; Ramezani M; Hashemi M
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):955-960. PubMed ID: 27327450
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an RP-HPLC method for CB13 evaluation in several PLGA nanoparticle systems.
Alvarez-Fuentes J; Martín-Banderas L; Muñoz-Rubio I; Holgado MA; Fernández-Arévalo M
ScientificWorldJournal; 2012; 2012():737526. PubMed ID: 22792051
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.
Ali H; Kalashnikova I; White MA; Sherman M; Rytting E
Int J Pharm; 2013 Sep; 454(1):149-57. PubMed ID: 23850397
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing nanoparticle drug release mechanisms by asymmetric flow field-flow fractionation.
Shakiba S; Shariati S; Wu H; Astete CE; Cueto R; Fini EH; Rodrigues DF; Sabliov CM; Louie SM
J Control Release; 2022 Dec; 352():485-496. PubMed ID: 36280154
[TBL] [Abstract][Full Text] [Related]
13. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor activity in A431 cells via encapsulation of 20(R)-ginsenoside Rg3 in PLGA nanoparticles.
Zhang S; Liu J; Ge B; Du M; Fu L; Fu Y; Yan Q
Drug Dev Ind Pharm; 2017 Oct; 43(10):1734-1741. PubMed ID: 28581836
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.
Pirooznia N; Hasannia S; Lotfi AS; Ghanei M
J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686
[TBL] [Abstract][Full Text] [Related]
17. Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization.
Ebrahimian M; Mahvelati F; Malaekeh-Nikouei B; Hashemi E; Oroojalian F; Hashemi M
Appl Biochem Biotechnol; 2022 Aug; 194(8):3733-3748. PubMed ID: 35507250
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies.
Chen G; Svirskis D; Wen J
J Pharm Pharmacol; 2015 Nov; 67(11):1528-36. PubMed ID: 26369422
[TBL] [Abstract][Full Text] [Related]
19. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
20. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
